Strategic Wealth Advisors Group, LLC Abb Vie Inc. Transaction History

Strategic Wealth Advisors Group, LLC

$2.33 Billion
Q3 2022

A detailed history of Strategic Wealth Advisors Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Wealth Advisors Group, LLC holds 45,968 shares of ABBV stock, worth $8.27 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

45,968

Previous 48,132 4.5%

Holding current value

$8.27 Million

Previous $7.35 Million 16.03%

% of portfolio

0.27%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $290,430 - $333,104	-2,164 Reduced 4.5%	45,968 $6.17 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $1.55 Million - $1.97 Million	11,281 Added 30.61%	48,132 $7.35 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $1.1 Million - $1.37 Million	8,339 Added 29.25%	36,851 $5.96 Million
Q4 2021 Feb 16, 2022	SELL	$107.43 - $135.93 $499,871 - $632,482	-4,653 Reduced 14.03%	28,512 $3.86 Million
Q3 2021 Nov 17, 2021	BUY	$106.4 - $120.78 $859,712 - $975,902	8,080 Added 32.21%	33,165 $3.58 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $290,800 - $323,968	2,764 Added 12.38%	25,085 $2.83 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $183,117 - $201,589	-1,790 Reduced 7.42%	22,321 $2.42 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $122,183 - $164,961	1,518 Added 6.72%	24,111 $2.58 Million
Q3 2020 Nov 30, 2020	BUY	$85.91 - $100.83 $208,589 - $244,815	2,428 Added 12.04%	22,593 $1.98 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $285,042 - $381,429	-3,885 Reduced 16.15%	20,165 $2.01 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $51,406 - $77,938	797 Added 3.43%	24,050 $1.77 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $224,035 - $280,316	3,106 Added 15.42%	23,253 $2.06 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $31,552 - $37,935	-501 Reduced 2.43%	20,147 $1.48 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $204,392 - $261,261	3,111 Added 17.74%	20,648 $1.5 Million
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $78,914 - $92,878	1,023 Added 6.19%	17,537 $0
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.29 Million - $1.59 Million	16,514 New	16,514 $1.47 Million
Q2 2018 Sep 17, 2018	SELL	$89.78 - $106.23 $3.13 Million - $3.7 Million	-34,839 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $1.5 Million - $2.01 Million	16,338 Added 88.31%	34,839 $3.3 Million
Q4 2017 Mar 08, 2018	BUY	$89.56 - $98.21 $1.66 Million - $1.82 Million	18,501 New	18,501 $1.79 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $1.94 Million - $2.47 Million	-27,740 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	27,740	27,740 $2.01 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.

Account

Strategic Wealth Advisors Group, LLC Abb Vie Inc. Transaction History